| Title |
ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer
|
|---|---|
| Published in |
Annals of Surgical Oncology, November 2019
|
| DOI | 10.1245/s10434-019-08057-5 |
| Pubmed ID | |
| Authors |
Nobuhiro Nakazawa, Takehiko Yokobori, Andrei Turtoi, Ken Shirabe |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 9 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 67% |
| Student > Doctoral Student | 1 | 11% |
| Student > Master | 1 | 11% |
| Unknown | 1 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 5 | 56% |
| Medicine and Dentistry | 2 | 22% |
| Biochemistry, Genetics and Molecular Biology | 1 | 11% |
| Unknown | 1 | 11% |